Premature ejaculation controlled by topical 4% benzocaine wipes | AUA
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
Topical 4% benzocaine wipes control premature ejaculation (PE).
Why this matters
PE is the most common form of sexual dysfunction in men, yet few safe and effective therapies exist.
Researchers at St. Barnabas Hospital in Bronx, New York, conducted a randomized controlled trial of topical 4% benzocaine wipes for the control of PE.
Participants were 21 adult men in heterosexual, monogamous relationships who had PE defined by self-reported poor control over ejaculation, personal distress related to ejaculation, and an average intravaginal ejaculatory latency time (IELT) at, or below, two minutes.